Kanavos, Inc. Launches Cannabis Business Advisory Board with Industry Trailblazers at Benzinga Cannabis Capital Conference

CHICAGO - June 9, 2025 - PRLog -- Benzinga Cannabis Capital Conference -  Kanavos Inc,  a trailblazer in Organizing the World's Cannabinoid Knowledge Through its Semantic AI Knowledge Graph is proud to announce the formation of its Founding Cannabis Business Advisory Board, comprised of some of the most accomplished and well respected leaders in the cannabis industry.

This milestone is being unveiled today during the Benzinga Cannabis Capital Conference in Chicago, where Kanavos is featured on the main stage as a thought leader in the Novel Cannabinoid Therapeutic Industry.

Joining the Kanavos Business Advisory Board are:

• Seth Yakatan – With over three decades of experience in corporate finance, Seth Yakatan has established himself as a prominent figure and sage thought leader in the cannabis, wellness and biotech sectors.
• Dennis O'Malley – Former COO of The Parent Company and past CEO of Caliva, Dennis brings deep operational experience scaling vertically integrated cannabis companies and current Principal at Echtrai.
• Jim Hourigan – Accomplished Cannabis and CPG Executive with a strong track record of scaling high-growth businesses. Proven expertise in operations,  supply chain optimization, and advanced manufacturing, with a focus on operational excellence and sustainable growth.
• Todd Blaschka – C-suite operator and with deep GTM experience scaling AI, data, and biotech startups across health tech and cannabis.
• Dan Poirier – Accomplished cannabis operator, advisor, and former CEO of CLIP Labs, with over a decade of experience building startups in the climate tech, defense tech and cannabis industries.

"We are honored to welcome this exceptional group of advisors whose leadership, vision, and operational depth span the cannabis, high tech, biotechnology, capital markets, cannabis health & wellness innovation and The Novel Cannabinoid Therapeutic Industry landscapes," said Steve Bastasini Kanavos, CEO. "As Kanavos accelerates its mission to organize and activate the world's cannabinoid science through our Semantic AI Knowledge graph, this advisory board ensures we are guided by real-world execution experience at every stage."

Members of the Kanavos Cannabis Business Advisory Board will play a critical role in shaping Kanavos' go-to-market strategy, scaling operations, and identifying high-value growth opportunities. Their collective expertise in capital markets, novel cannabinoid innovation, and cannabis operations will provide Kanavos with strategic guidance as we commercialize our

Semantic AI Knowledge Graph platform and unlock new value across the cannabinoid therapeutics ecosystem.

"What Kanavos is doing with its Cannabis Knowledge Graph is potentially revolutionary and allows for actionable decisions…" said Seth Yakatan

As Kanavos prepares for its upcoming funding milestones and deepens partnerships across the cannabis, cannabis health & wellness and novel cannabinoid sectors, the guidance of the advisory board will be instrumental in aligning investor priorities with long-term market transformation.

Kanavos Business advisors bring decades of experience scaling cannabis businesses, executing high-growth strategies, and driving innovation in novel cannabinoid therapeutics. Their strategic input will support:

• Go-to-market execution for the Kanavos Semantic AI Knowledge Graph
• Investor alignment as Kanavos' approaches upcoming funding milestones
• Partnership development across wellness, nutrition, digital health sectors
• Positioning Kanavos as a the defining Semantic AI Knowledge Graph platform for scientific evidence-based cannabinoid therapeutics

The Kanavos Cannabis Business Advisory Board will shape go-to-market execution, scale operations, and guide strategic growth. With deep expertise across capital markets, cannabinoid innovation, and cannabis operations, the board's insights will support commercialization of Kanavos' Semantic AI Knowledge Graph and its position as the leading intelligence platform in novel cannabinoid therapeutics.

"This board brings the real-world experience needed to navigate complexity and drive value," said Deborah McGuinness , Co-Founder of Kanavos. "Their leadership ensures we stay aligned with investor priorities while accelerating our vision to unlock the therapeutic potential of cannabinoids through science and AI."

About Kanavos
Kanavos, a leader in the Novel Cannabinoid Therapeutic Industry is revolutionizing cannabinoid-based medicine by developing the world's first comprehensive and provenance-aware Semantic AI Cannabinoid Knowledge Graph, providing patients, researchers, and healthcare providers with a unified source of truth to discover scientific, evidence-based therapeutic treatments empowering personalized actionable decisions.

About the Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference is the premier gathering of cannabis investors and operators in North America. This June, the Chicago event brings together founders, funders, and policymakers shaping the next phase of industry growth through science, strategy, and innovation.

Contact Information

Steve Bastasini
CEO - Kanavos
415-740-5528
steve@kanavos.io
For more information, please visit: www.kanavos.ai